Adipose tissue senescence: a potential link between sleep apnea and cardiovascular disease
Description: Obstructive sleep apnea (OSA) is a highly prevalent disorder that affects more than 20 million US adults. Multiple studies demonstrate that OSA contributes to cardiovascular disease (CVD), and thus may be a novel target to reduce cardiovascular risk. However, the underlying pathophysiology and molecular mechanistic pathways which increase CVD risk in OSA patients are poorly understood. Insights into the contributing pathological mechanisms will be crucial to develop alternate treatment strategies - especially given the low patient compliance in using standard CPAP (continuous positive airway pressure) therapy for OSA treatment. Increasing evidence from obesity and aging studies also suggest the role of senescence in contributing to adipose tissue dysfunction, and thus increasing the risk of CVD. Our proposed studies aim to investigate the link between OSA and adipose tissue senescence. We hypothesize that intermittent hypoxia (IH) experienced by OSA patients promotes premature adipose tissue senescence, which may result in altered adipose tissue function, and an increased CVD risk. This hypothesis is supported by our strong preliminary data showing: 1) increased accumulation of senescent cells in the adipose tissue of OSA subjects; 2) IH-induced senescence in cultured human white preadipocytes (HWP); and 3) prevention of IH-mediated senescence by anti-inflammatory and anti-oxidant agents. To test our hypothesis, we will demonstrate an increased accumulation of senescent cells and inflammation in adipose tissue, along with the presence of adipose tissue insulin-resistance in OSA subjects (Aim 1). We will also use a unique model of IH mimicking repeated hypoxic events experienced by OSA subjects to demonstrate and mechanistically examine the role of IH in triggering senescence in cultured HWP and in adipose tissue from healthy subjects (ex-vivo studies) (Aim 2 and Aim 3). The novelty of our study is in identification of the role of IH in development and accumulation of senescent cells in adipose tissue. Our findings may be pivotal in designing new approaches and interventions for OSA treatment to control/reduce cardiovascular risk. Furthermore, these results will also potentially advance aging research aimed to prevent/decrease chronic inflammatory processes, such as osteoarthritis, Alzheimer's and cardiovascular disease in general. Our data may also provide a basis for understanding OSA as a process of accelerated cardiovascular aging.
Funder: American Heart Association
Amount: $102,600
Funding type: fellowship
Funder scheme: Postdoctoral Fellowship
Start date: 2016-07-01
End date: 2018-06-30
Investigator: Katarzyna Polonis (lead)
Institutions: Mayo Clinic, MAYO CLINIC, ROCHESTER, MN
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Funded outputs count: 1
Funder award ID: 16POST30260005
OpenAlex ID: G3669354890
